NO20065297L - Anvendelse av GPCR54 ligander til behandling av infertilitet - Google Patents

Anvendelse av GPCR54 ligander til behandling av infertilitet

Info

Publication number
NO20065297L
NO20065297L NO20065297A NO20065297A NO20065297L NO 20065297 L NO20065297 L NO 20065297L NO 20065297 A NO20065297 A NO 20065297A NO 20065297 A NO20065297 A NO 20065297A NO 20065297 L NO20065297 L NO 20065297L
Authority
NO
Norway
Prior art keywords
gpcr54
ligands
treat infertility
infertility
treat
Prior art date
Application number
NO20065297A
Other languages
English (en)
Norwegian (no)
Inventor
Robert K Campbell
Xuliang Jiang
Shoji Nagatani
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20065297L publication Critical patent/NO20065297L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO20065297A 2004-04-23 2006-11-17 Anvendelse av GPCR54 ligander til behandling av infertilitet NO20065297L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56475604P 2004-04-23 2004-04-23
PCT/US2005/013339 WO2005117939A2 (en) 2004-04-23 2005-04-19 Use of gpcr54 ligands for the treatment of infertility

Publications (1)

Publication Number Publication Date
NO20065297L true NO20065297L (no) 2006-11-17

Family

ID=35463344

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065297A NO20065297L (no) 2004-04-23 2006-11-17 Anvendelse av GPCR54 ligander til behandling av infertilitet

Country Status (7)

Country Link
EP (1) EP1750513A4 (de)
JP (1) JP2007533748A (de)
AU (1) AU2005249373A1 (de)
CA (1) CA2562676A1 (de)
IL (1) IL178795A0 (de)
NO (1) NO20065297L (de)
WO (1) WO2005117939A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091567A1 (es) 2004-06-25 2009-11-03 Takeda Pharmaceutical Derivados de metastina en el tratamiento del cancer
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
TWI404726B (zh) 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
KR20100058555A (ko) * 2007-09-11 2010-06-03 몬도바이오테크 래보래토리즈 아게 치료제로서의 bpp-b의 용도
GB0719592D0 (en) 2007-10-08 2007-11-14 Medical Res Council Compound, use and method
PL2314609T3 (pl) * 2008-07-30 2017-07-31 Takeda Pharmaceutical Company Limited Pochodne metastyny i ich zastosowanie
EP2340047A1 (de) * 2008-09-19 2011-07-06 Nektar Therapeutics Polymerkonjugate von kiss1-peptiden
CA2737040C (en) 2008-09-19 2017-05-02 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US9127038B2 (en) 2011-08-04 2015-09-08 Merck Sharp & Dohme Corp. Kisspeptide-pentasaccharide conjugates
US20150087610A1 (en) * 2012-03-20 2015-03-26 Monell Chemcial Senses Center Method of Modifying Fertility
FR3001455B1 (fr) 2013-01-31 2017-10-06 Agronomique Inst Nat Rech Composes agonistes du recepteur kiss1r et leur utilisation pour induire l'ovulation chez les mammiferes
TW201605907A (zh) * 2014-08-12 2016-02-16 國立臺灣大學 一種調控精子授精能力短鏈胜肽之提高體外人工授精成功率之用途
IL311335A (en) 2016-09-30 2024-05-01 Sumitomo Pharma Switzerland Gmbh Methods for treating female infertility
CN109125307B (zh) * 2018-09-03 2021-05-07 河南牧翔动物药业有限公司 一种克罗米酚-多肽复合物、药物制剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1761680A (zh) * 2002-12-26 2006-04-19 武田药品工业株式会社 肿瘤迁移抑制素衍生物及其用途
EP1604682A4 (de) * 2003-03-12 2009-06-24 Takeda Chemical Industries Ltd Mittel zur verbesserung der gonadenfunktion

Also Published As

Publication number Publication date
EP1750513A4 (de) 2009-07-22
WO2005117939A2 (en) 2005-12-15
JP2007533748A (ja) 2007-11-22
CA2562676A1 (en) 2005-12-15
AU2005249373A1 (en) 2005-12-15
EP1750513A2 (de) 2007-02-14
WO2005117939A9 (en) 2006-04-20
IL178795A0 (en) 2007-03-08
WO2005117939A3 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
NO20065297L (no) Anvendelse av GPCR54 ligander til behandling av infertilitet
NO20092637L (no) Fremgangsmater for behandling
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
DE602005026508D1 (de) Monozyklische heterozyklen als kinase-hemmer
DE602005020645D1 (de) Zusammensetzungen und verfahren für die tumor-diagnose und behandlung
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
EA200602221A1 (ru) Новое применение пептидных соединений для лечения боли при тригеминальной невралгии
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
TW200605886A (en) Indazoles useful in treating cardiovascular diseases
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
NO20065859L (no) Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser
EA200700225A1 (ru) Аналоги тетрапептида
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA201070247A1 (ru) Ингибиторы протеасом
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
DE602005009748D1 (de) 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors
TW200716546A (en) Oxindole compounds and their uses as therapeutic agents
NO20065251L (no) Anvendelse av peptidiske forbindelser for profilakse og behandling av kronisk hodepine
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
ATE432279T1 (de) Tricyclische delta-opioid-modulatoren
NO20075764L (no) Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application